These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27706615)

  • 41. Meta-analysis of the human leukocyte antigen-G (HLA-G) 14 bp insertion/deletion polymorphism as a risk factor for preeclampsia.
    Pabalan N; Jarjanazi H; Sun C; Iversen AC
    Tissue Antigens; 2015 Sep; 86(3):186-94. PubMed ID: 26202804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The maternal 14 bp Ins/Del polymorphism in HLA-G is not associated with preeclampsia risk.
    Ferreira LC; Lopes TPB; Guimarães TB; Gomes CEM; Jeronimo SMB
    Int J Immunogenet; 2017 Dec; 44(6):350-355. PubMed ID: 29105301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An HLA-G(∗)14bp insertion/deletion polymorphism associates with the development of autistic spectrum disorders.
    Guerini FR; Bolognesi E; Chiappedi M; Ghezzo A; Canevini MP; Mensi MM; Vignoli A; Agliardi C; Zanette M; Clerici M
    Brain Behav Immun; 2015 Feb; 44():207-12. PubMed ID: 25451607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection.
    Catamo E; Zupin L; Freato N; Polesello V; Celsi F; Crocè SL; Masutti F; Pozzato G; Segat L; Crovella S
    HLA; 2017 Mar; 89(3):135-142. PubMed ID: 28083985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
    Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
    HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3'-untranslated region.
    Svendsen SG; Hantash BM; Zhao L; Faber C; Bzorek M; Nissen MH; Hviid TV
    Hum Immunol; 2013 Jul; 74(7):818-27. PubMed ID: 23583363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "HLA-G 3'UTR gene polymorphisms and rheumatic heart disease: a familial study among South Indian population".
    Poomarimuthu M; Elango S; Soundrapandian S; Mariakuttikan J
    Pediatr Rheumatol Online J; 2017 Feb; 15(1):10. PubMed ID: 28143491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.
    Zidi I; Ben Yahia H; Bortolotti D; Mouelhi L; Laaribi AB; Ayadi S; Zidi N; Houissa F; Debbech R; Boudabous A; Najjar T; Di Luca D; Rizzo R
    Int Immunol; 2015 Jun; 27(6):289-96. PubMed ID: 25577194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Analysis of HLA-G in Women with High-Risk Pregnancy and Their Partners with Regard to Possible Complications.
    Sipak O; Rył A; Grzywacz A; Laszczyńska M; Szymański S; Karakiewicz B; Rotter I; Cybulski C
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30893814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of HLA-G 3'UTR polymorphisms with response to malaria infection: a first insight.
    Garcia A; Milet J; Courtin D; Sabbagh A; Massaro JD; Castelli EC; Migot-Nabias F; Favier B; Rouas-Freiss N; Donadi EA; Moreau P
    Infect Genet Evol; 2013 Jun; 16():263-9. PubMed ID: 23499774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G.
    Dahl M; Klitkou L; Christiansen OB; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Hviid TV
    Hum Immunol; 2015 Apr; 76(4):260-71. PubMed ID: 25637667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infection.
    de Oliveira Crispim JC; Silva TG; Souto FJ; Souza FF; Bassi CL; Soares CP; Zucoloto S; Moreau P; Martinelli Ade L; Donadi EA
    Hum Immunol; 2012 Mar; 73(3):258-62. PubMed ID: 22178697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
    Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
    Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Association of
    Piekarska K; Radwan P; Tarnowska A; Wiśniewski A; Krasiński R; Radwan M; Wilczyński JR; Malinowski A; Nowak I
    Front Immunol; 2021; 12():791399. PubMed ID: 35111159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The immunosuppressive molecule HLA-G and its clinical implications.
    González A; Rebmann V; LeMaoult J; Horn PA; Carosella ED; Alegre E
    Crit Rev Clin Lab Sci; 2012; 49(3):63-84. PubMed ID: 22537084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.
    El-Chennawi FA; Auf FA; Metwally SS; Mosaad YM; El-Wahab MA; Tawhid ZE
    Immunol Invest; 2008; 37(7):661-74. PubMed ID: 18821214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA-G 14-bp Ins/Ins Genotype in Patients Harbouring Helicobacter pylori Infection: A Potential Risk Factor?
    Genre J; Reginaldo FP; Andrade JM; Lima FP; da Camara AV; Donadi EA; Crispim JC
    Scand J Immunol; 2016 Jan; 83(1):52-7. PubMed ID: 26368842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An indel polymorphism in the 3' untranslated region of HMGB1 confers risk for hepatocellular carcinoma by regulating HMGB1 transcriptional activity in a Chinese population.
    Wang J; Zhu J; Mao DH; Zhu S; Mi XG; Yu Q
    Neoplasma; 2020 Jan; 67(1):61-67. PubMed ID: 31777261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
    Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis.
    Chiusolo P; Bellesi S; Piccirillo N; Giammarco S; Marietti S; De Ritis D; Metafuni E; Stignani M; Baricordi OR; Sica S; Leone G; Rizzo R
    Bone Marrow Transplant; 2012 Jan; 47(1):120-4. PubMed ID: 21399669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.